Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,834
  • Shares Outstanding, K 64,818
  • Annual Sales, $ 2,240 K
  • Annual Income, $ -136,670 K
  • 60-Month Beta 1.33
  • Price/Sales 82.36
  • Price/Cash Flow N/A
  • Price/Book 1.02
Trade IPSC with:

Options Overview Details

View History
  • Implied Volatility 576.37% ( +359.78%)
  • Historical Volatility 93.64%
  • IV Percentile 99%
  • IV Rank 81.36%
  • IV High 701.39% on 11/15/23
  • IV Low 30.54% on 01/18/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 26
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 516
  • Open Int (30-Day) 438

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 3
  • High Estimate -0.45
  • Low Estimate -0.53
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +5.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +12.36%
on 04/18/24
5.24 -41.02%
on 03/21/24
-1.71 (-35.63%)
since 03/19/24
3-Month
2.75 +12.36%
on 04/18/24
5.51 -43.92%
on 03/08/24
-0.74 (-19.32%)
since 01/19/24
52-Week
1.28 +141.41%
on 11/13/23
5.51 -43.92%
on 03/08/24
-0.06 (-1.90%)
since 04/19/23

Most Recent Stories

More News
Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Lags Revenue Estimates

Century Therapeutics, Inc. (IPSC) delivered earnings and revenue surprises of 0% and 23.89%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

IPSC : 3.09 (+3.87%)
CTLT : 55.48 (-0.57%)
Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 14.29% and 68.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 34.92 (-2.54%)
IPSC : 3.09 (+3.87%)
Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates

Century Therapeutics, Inc. (IPSC) delivered earnings and revenue surprises of 8.33% and 81.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

IPSC : 3.09 (+3.87%)
IMPL : 0.0400 (-27.27%)
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?

Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.

YMAB : 15.13 (+0.87%)
IPSC : 3.09 (+3.87%)
EDIT : 5.49 (-1.08%)
FATE : 4.79 (-4.96%)
JNJ : 147.91 (+1.49%)
ELEV : 3.80 (-5.24%)
After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC)

Century Therapeutics, Inc. (IPSC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts...

IPSC : 3.09 (+3.87%)
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates

Century Therapeutics, Inc. (IPSC) delivered earnings and revenue surprises of 10.17% and 42.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

IPSC : 3.09 (+3.87%)
GANX : 3.18 (+0.95%)
Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

- Following the recent submission of the IND application for CNTY-101 and pending FDA clearance, the Phase 1 ELiPSE-1 trial in relapsed/refractory lymphoma...

IPSC : 3.09 (+3.87%)
Century Therapeutics Announces Its Addition to the Russell Microcap® Index

PHILADELPHIA, June 24, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 3.09 (+3.87%)
Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

PHILADELPHIA, June 21, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 3.09 (+3.87%)
Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022

PHILADELPHIA, June 06, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent...

IPSC : 3.09 (+3.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

See More

Key Turning Points

3rd Resistance Point 3.52
2nd Resistance Point 3.36
1st Resistance Point 3.22
Last Price 3.09
1st Support Level 2.93
2nd Support Level 2.77
3rd Support Level 2.63

See More

52-Week High 5.51
Fibonacci 61.8% 3.89
Fibonacci 50% 3.39
Last Price 3.09
Fibonacci 38.2% 2.90
52-Week Low 1.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar